HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Clinical trials for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vaccine trains immune system to fight HPV-Positive head and neck tumors
Disease control Recruiting nowThis trial tests a vaccine called BVAC-E6E7 in people with head and neck cancer linked to HPV types 16 or 18 that cannot be removed by surgery or has spread. The vaccine is designed to teach the immune system to attack cancer cells. The study first checks safety and the best dose…
Matched conditions: HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Cellid Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New combo treatment may spare head and neck cancer patients from disfiguring surgery
Disease control Recruiting nowThis study tests giving chemotherapy and immunotherapy before standard surgery for head and neck cancer. The goal is to shrink tumors enough so that surgeons can perform less extensive, function-preserving operations, reducing damage to swallowing, speech, and vision. The trial e…
Matched conditions: HPV (HUMAN PAPILLOMAVIRUS)-ASSOCIATED CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC